A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer

Environmental Health Perspectives
G UrsinMalcolm C Pike

Abstract

The two main pathways for metabolizing estrogen are via 16alpha-hydroxylation and 2-hydroxylation. The 16alpha-hydroxy metabolites are biologically active; the 2-hydroxy metabolites are not. It is suggested that women who metabolize a larger proportion of their endogenous estrogen via the 16alpha-hydroxy pathway may be at significantly elevated risk of breast cancer compared with women who metabolize proportionally more estrogen via the 2-hydroxy pathway. In particular, it is suggested that the ratio of urinary 2-hydroxyestrone (2-OHE1) to 16alpha-hydroxyestrone (16alpha-OHE1) is an index of reduced breast cancer risk. This pilot study compared this ratio in postmenopausal women diagnosed with breast cancer to those of healthy controls. Urinary concentrations of estrone (E1), 17beta-estradiol (E2) and estriol (E3) were also quantified. White women who were subjects in a previous breast cancer case-control study at our institution were eligible for inclusion. All participants provided a sample of their first morning urine. The results from the first 25 cases and 23 controls are presented here. The ratio of 2-OHE1 to 16alpha-OHE1 was 12% lower in the cases (p=0.58). However, urinary E1 was 30% higher (p=0.10), E2 was 58% higher (...Continue Reading

References

May 22, 1976·Lancet·I J McFadyenK Griffiths
May 1, 1975·Journal of Steroid Biochemistry·J H ThijssenF Schwarz
Dec 1, 1990·American Journal of Obstetrics and Gynecology·D L CassidentiR A Lobo
Aug 3, 1989·The New England Journal of Medicine·R A Galbraith, J J Michnovicz
Jan 1, 1986·Annals of the New York Academy of Sciences·H L BradlowJ Fishman
Dec 1, 1988·American Journal of Obstetrics and Gynecology·F Z StanczykR A Lobo
Jan 1, 1986·Annals of the New York Academy of Sciences·P K SiiteriJ Murai
May 1, 1987·American Journal of Epidemiology·D K WysowskiH L Lau
Jun 1, 1987·The Journal of Clinical Endocrinology and Metabolism·C LongcopeJ Warram
Oct 1, 1987·The Journal of Clinical Endocrinology and Metabolism·P I MuseyJ R Preedy
Jan 27, 1973·Lancet·A E ArgüellesO Blanchard
Dec 1, 1974·British Journal of Cancer·P C EnglandR A Sellwood
Feb 1, 1973·The Journal of Clinical Endocrinology and Metabolism·J M GrodinP C MacDonald
Oct 1, 1968·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Grönroos, A J Aho
Jul 1, 1980·Journal of Steroid Biochemistry·D DraftaI Bălănescu
Aug 24, 1981·Life Sciences·A R HoffmanS M Paul
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J SchneiderJ Fishman
Sep 1, 1980·The Journal of Clinical Endocrinology and Metabolism·J Fishman, C Martucci
Jan 15, 1982·International Journal of Cancer. Journal International Du Cancer·J W MooreP K Siiteri
Jan 18, 1995·Journal of the National Cancer Institute·L LipworthE Petridou
Jan 1, 1995·Nutrition and Cancer·J L FreudenheimT Nemoto
Apr 1, 1962·The Journal of Clinical Endocrinology and Metabolism·J FISHMANT F GALLAGHER
Jun 15, 1965·American Journal of Obstetrics and Gynecology·J MARMORSTONC E HOPKINS

❮ Previous
Next ❯

Citations

Jun 16, 2000·Environmental Health Perspectives·S H Safe
Aug 8, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alan A ArslanAnne Zeleniuch-Jacquotte
Jan 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica M Faupel-BadgerRegina G Ziegler
Feb 23, 2012·Open Journal of Preventive Medicine·Kerryn W RedingJohanna W Lampe
Jun 1, 2002·Breast Cancer Research and Treatment·Giske UrsinElisabet Gentzschein
Sep 6, 2005·Breast Cancer Research and Treatment·Francesmary ModugnoJane A Cauley
Apr 5, 2014·Nutrition Reviews·Emma S BrownEmeir M McSorley
Apr 18, 2015·Frontiers in Physiology·Andrea G BraundmeierBryan A White
Aug 25, 2001·The British Journal of Nutrition·F BrancaH Verhagen
Nov 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ewa SawickaAgnieszka Piwowar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.